Cambridge, United Kingdom

Louisa Jane Cubitt

This inventor holds 2 USPTO granted patents, plus 2 CIPO patents. Top assignee: Paion UK Limited. Active years: 2014-2015.


% Patents Active = 100.0


Average Co-Inventor Count = 2.0

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2014-2015

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Louisa Jane Cubitt: Innovator in Benzodiazepine Salts

Introduction

Louisa Jane Cubitt is a notable inventor based in Cambridge, GB. She has made significant contributions to the field of medicinal chemistry, particularly in the development of short-acting benzodiazepine salts. With a total of two patents to her name, her work has implications for various therapeutic applications.

Latest Patents

Louisa's latest patents focus on short-acting benzodiazepine salts and their polymorphic forms. The first patent describes besylate salts of a specific compound, detailing methods of preparing these salts and their use as medicaments. These salts are particularly relevant for sedative or hypnotic, anxiolytic, muscle relaxant, or anticonvulsant purposes. The second patent similarly addresses esylate salts of the same compound, emphasizing their preparation methods and therapeutic applications.

Career Highlights

Louisa is currently employed at Paion UK Limited, where she continues to advance her research in pharmacology. Her work has been instrumental in developing new medications that can improve patient outcomes in various medical conditions.

Collaborations

Louisa collaborates with Gary Stuart Tilbrook, contributing to the innovative research environment at Paion UK Limited. Their partnership exemplifies the collaborative spirit that drives advancements in the pharmaceutical industry.

Conclusion

Louisa Jane Cubitt's contributions to the field of benzodiazepine salts highlight her role as a significant inventor in medicinal chemistry. Her patents reflect her commitment to improving therapeutic options for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…